Partners

Cooperating partners

Asia Pacific Alliance for Obesity and Sarcopenia Metabolism (APAOSM)

About: As a distinguished academic organization, APAOSM is dedicated to advancing research, education, and awareness in obesity and sarcopenia within the Asian population.

Website: https://www.apaosm.org/

ResearchGate

Website: https://www.researchgate.net/journal/Metabolism-and-Target-Organ-Damage-2769-6375

Fatty Liver Alliance

About: The Fatty Liver Alliance raises awareness and educates Canadians about the risks, causes, and complications of fatty liver disease and helps those already diagnosed with nonalcoholic fatty liver disease (NAFLD), metabolic associated fatty liver disease (MAFLD), and nonalcoholic steatohepatitis (NASH) by advocating for access to approved treatments and care.

Website: https://fattyliver.ca/

Kent Ridge Metabolic Group

About: Kent Ridge Metabolic Group is based in Singapore and positions itself as the pinnacle research team in the field of metabolic health, devoted to furthering the study of a plethora of research fields such as hepatology including Non-alcoholic Fatty Liver Disease, Hepatocellular Carcinoma, and Liver Transplantation. Kent Ridge Metabolic Group also focuses on other research fields, including cardiometabolic diseases, obesity, and diabetes.

MAIDEN

About:

MAIDEN, the METABOLIC FATTY LIVER DISEASE CONSORTIUM, founded in 2022, is a medical association dedicated to pursuing excellence in liver research, to the clinical practice of fatty liver disease, and to providing education to all those interested in MAFLD and to be the official body to represent APASL on any matters related to fatty liver disease.

MAIDEN VISION: Many ways, one aim: A world in which no one suffers from the consequences of MAFLD.

Website: https://maiden-apasl.com

Medical Digest congress report

About: Since our launch in 2013, the CongressReport.eu portal has aimed to open a window to the world congresses for those who are unable to visit the event due to financial restrictions, strict travel regulations, or job-related commitments.

Website: https://medicaldigest.org/

Cooperating conferences

8th Heart in Diabetes

Time and Venue: June 7-9, 2024 | Philadelphia，USA

About:

The Heart in Diabetes (HiD) conference, entering its eighth year, is a renowned medical meeting that brings together global clinical leaders in diabetes, obesity, and cardiorenal metabolic diseases together with practicing clinicians to improve the care of patients at a high risk of these comorbidities. This is a unique and exciting multidisciplinary program: Where the Heart, Kidney, and Diabetes Meet in Clinical Practice.

Following a successful meeting in 2023, the Heart in Diabetes Conference is looking forward to hosting another conference in Philadelphia. The 8^th HiD 2024 will be held at the Hilton Penn's Landing in Philadelphia, PA from June 7-9, 2024. This is a live-in-person conference followed by 90 days on demand. The conference will offer 27 CME / MOC credits.

To register, visit: https://www.heartindiabetes.com/registration

Website: https://www.heartindiabetes.com/

The 21st Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)

Time and Venue: December 7-9, 2023 | Los Angeles，USA

About: The 21st Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) Conference is set to convene from December 7 to 9, 2023, at the heart of Los Angeles. This highly anticipated event promises a dynamic blend of in-person engagement and on-demand accessibility, catering to both on-site and remote participants.
Under the theme "Exploring New Frontiers in Metabolism—Tomorrow's Clinical Science Today," WCIRDC has evolved into the preeminent global platform dedicated to the convergence of metabolism, obesity, diabetes, and cardiovascular, kidney, and liver diseases.

Website: https://www.wcir.org/

CME Diabetes, Obesity and Cholesterol Metabolism Conference

Time and Venue: December 5-6, 2022 | Abu Dhabi, UAE.

About: CME Diabetes, Obesity and Cholesterol Metabolism Conference aims to point toward the investigation of diet imbalance as a tool for weight management and irradiate negative consequences & implications for health that causes obesity, diabetes & metabolic disorders.
PDOC 2022 will provide the platform for Diabetologists, Endocrinologists, Nutritionists, and other related Professionals to present their latest research works. It aims for invaluable scientific discussions and contributes to the future innovations & recent trends in the areas of Diabetes, Obesity, and Endocrinology and also brings together an interdisciplinary and global team of research professionals.

Website: https://metabolicdiseases.plenareno.com/

The 7th IFSO APC MEETING

Time and Venue: November 3-4, 2022 | Manila, Philippines

About: After 2 long years, surviving the pandemic, getting vaccinated 4 times, and adjusting to the “new normal”, the FACE-TO-FACE Meeting is back. It is an honor and privilege to invite you to the 7th IFSO APC MEETING in Manila, Philippines this November 3 and 4, 2022.

The venue will be at the prestigious SHANGRI-LA THE FORT HOTEL in the new Business District of Bonifacio Global City. We are excited to see old and new friends, discuss and collaborate with experts, and best of all, enjoy travelling once again. This will be the first time the event will be held in the Philippines, so expect a journey into paradise as the Philippines is known for its unique and diverse cultural heritage, beautiful tropical landscape, and loving and caring people.

The theme of the Meeting is called “TEAM WORK MAKES THE DREAM WORK” and is focused on the multi-disciplinary approach to treating obesity and diabetes. There will be lectures, videos, debates and discussions on management, controversies, and complications in the treatment of obesity and diabetes. International and local experts have been invited and the event is open to all doctors, medical and surgical, and integrated health specialists.